Globus Medical, Inc.
GMED · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3 | $2 | $1 | $1 |
| % Growth | 60.6% | 53.3% | 6.8% | – |
| Cost of Goods Sold | $1 | $1 | $0 | $0 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 58.9% | 65.1% | 74.2% | 75% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 6.6% | 8.5% | 22.3% | 17.9% |
| Other Income/Exp. Net | -$0 | $0 | $0 | $0 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 4.1% | 7.8% | 18.6% | 15.6% |
| EPS | 0.76 | 1.09 | 1.89 | 1.48 |
| % Growth | -30.3% | -42.3% | 27.7% | – |
| EPS Diluted | 0.75 | 1.07 | 1.85 | 1.44 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 18.8% | 22.1% | 29.8% | 27.6% |